Interventional oncology procedures comprise diagnosis and treatment of cancer with the help of minimally invasive procedures that are conducted under image guidance. The process utilizes equipment such as x-ray, ultrasound, computed tomography, or magnetic resonance imaging for guidance purposes. The procedures are carried out using guide accessories and instruments, including ablation electrodes, guidewires, biopsy needles, and intravascular catheters that enable the treatment of a tumor situated in remote parts of the body.
Interventional oncology is used to treat primary or metastatic cancer such as liver cancer, kidney cancer, lung cancer, bone cancer, prostate cancer, breast cancer, and pancreatic cancer. Most of these procedures are conducted either in an outpatient setting or needs an overnight stay in the hospital. Due to its minimally invasive nature, the recovery time required is minimal. Some of the popular procedures are pain palliation, intra-arterial therapies, ablative therapies, and neoadjuvant procedures.
The growing demand for minimally invasive therapeutics is the major driving factor for the market growth. These procedures could also be used to treat patients with other related comorbidities and in inoperable patients. The ability of minimally invasive techniques to treat cancerous cells better than alternative cancer treatments such as radiation therapy, surgeries, and systematic chemotherapy has helped the technique gain popularity.
Moreover, healthcare professionals and patients are gradually opting for minimally invasive procedures in the field of interventional oncology due to advantages of using these techniques such as shorter hospital stay, minimal risk of infection, minimal risk of complications, cause less pain, and faster recovery time in comparison to conventional surgeries. These advantages of using minimally invasive procedures will impel the growth of the global interventional oncology market.
The global interventional oncology market is segmented based on procedure and geography. Based on procedure, the market is categorized into radiation therapy, ablation, and particle embolization. Radiation therapy is further bifurcated into internal and external radiation therapy. Ablation is further categorized into cryoablation therapy, microwave ablation therapy, and radiofrequency ablation. Particle embolization is further classified into drug-eluting beads, radioembolization, microspheres, and polyvinyl alcohol particles. Based on geography, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as Boston Scientific, Accuray, Medtronic, AtriCure, Baylis Medical, BTG, Alpinion Medical Systems, Terumo Corporation, AngioDynamics, and Merit Medical have also been provided in this report.
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global market.
- This report entails a detailed quantitative analysis of the current market and estimations from 2017-2023, which helps identify prevailing market opportunities.
- The projections in this report are made by analyzing the current trends and future market potential from 2017 to 2023 in terms of value.
- Competitive intelligence helps understand the competitive scenario globally
- An in-depth analysis of current research and clinical developments within the market has been provided with key market dynamic factors that help understand the behavior of the market
Interventional Oncology Market Key Segments:
- Radiation Therapy
- Internal Radiation Therapy
- External Radiation Therapy
- Cryoablation Therapy
- Microwave Ablation Therapy
- Radiofrequency Ablation
- Particle Embolization
- Drug-Eluting Beads
- Polyvinyl Alcohol Particles
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA